Vitronectin antibody | 8E6 (1.110)
Mouse anti Human vitronectin antibody recognizes human vitronectin and will react with the native and denatured forms. It does not cross react with fibronectin.Vitronectin is one of the 2 most important cell adhesive proteins found in the blood and extracellular matrix. It exists as a mixture of 2 monomeric glycoproteins that mediate cell adhesion through an interaction between the R-G-D sequence, present in the cell binding domains, and several different integrin receptors. It is also known as a complement lysis inhibitor and as a scavenger protein for macromolecular products of the complement and homeostasis cascades.
- Target Species
- Product Form
- Purified IgG - liquid
- Purified IgG prepared by affinity chromatography on Protein G
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
0.09% Sodium Azide (NaN3)
- Purified vitronectin from human plasma.
- Approx. Protein Concentrations
- 1.0 mg/ml
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
- Shelf Life
- 18 months from date of despatch.
- P04004 Related reagents
- Entrez Gene
- VTN Related reagents
- GO Terms
- GO:0005044 scavenger receptor activity
- GO:0005178 integrin binding
- GO:0005615 extracellular space
- GO:0006955 immune response
- GO:0008201 heparin binding
- GO:0010951 negative regulation of endopeptidase activity
- GO:0014911 positive regulation of smooth muscle cell migration
- GO:0030195 negative regulation of blood coagulation
- GO:0030949 positive regulation of vascular endothelial growth factor receptor signaling pathway
- GO:0032092 positive regulation of protein binding
- GO:0033627 cell adhesion mediated by integrin
- GO:0048260 positive regulation of receptor-mediated endocytosis
- GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
- GO:0061302 smooth muscle cell-matrix adhesion
- GO:0071062 alphav-beta3 integrin-vitronectin complex
- GO:0090303 positive regulation of wound healing
- For research purposes only
Applications of Vitronectin antibody
|Application Name||Verified||Min Dilution||Max Dilution|
|ELISA||5 µg/ml||20 µg/ml|
|Immunohistology - Frozen||5 µg/ml||20 µg/ml|
|Western Blotting||5 µg/ml||20 µg/ml|
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using the appropriate negative/positive controls.
Copyright © 2018 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
Hayman, E.G. et al. (1983) Serum spreading factor (vitronectin) is present at the cell surface and in tissues.
Proc Natl Acad Sci U S A. 80 (13): 4003-7.
References for Vitronectin antibody
Gladson, C.L. & Cheresh, D.A. (1991) Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.
J Clin Invest. 88 (6): 1924-32.
Kost, C. et al. (1996) Limited plasmin proteolysis of vitronectin. Characterization of the adhesion protein as morpho-regulatory and angiostatin-binding factor.
Eur J Biochem. 236 (2): 682-8.
Kost, C. et al. (1992) Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
J Biol Chem. 267 (17): 12098-105.
Dahm, L.M. & Bowers, C.W. (1998) Vitronectin regulates smooth muscle contractility via alphav and beta1 integrin.
J Cell Sci. 111 ( Pt 9): 1175-83.
Aaboe, M. et al. (2003) Vitronectin in human breast carcinomas.
Biochim Biophys Acta. 1638 (1): 72-82.